Global Dna Vaccines Market Size & Outlook, 2020-2028
Global dna vaccines market, 2017-2028 (US$M)
Related Markets
Global dna vaccines market highlights
- The global dna vaccines market generated a revenue of USD 5,954.0 million in 2020 and is expected to reach USD 10,377.4 million by 2028.
- The market is expected to grow at a CAGR (2021 - 2028) of 7.2% by 2028.
- In terms of segment, recombinant vaccine accounted for a revenue of USD 5,954.0 million in 2020.
- Recombinant vaccine is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, U.S. is expected to register the highest CAGR from 2021 to 2028.
Global data book summary
| Market revenue in 2020 | USD 5,954.0 million |
| Market revenue in 2028 | USD 10,377.4 million |
| Growth rate | 7.2% (CAGR from 2020 to 2028) |
| Largest segment | Recombinant vaccine |
| Fastest growing segment | Recombinant vaccine |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Recombinant vaccine |
Other key industry trends
- In terms of revenue, the North America accounted for 48.0% of the global dna vaccines market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2028.
- By country, U.S. is the fastest growing regional market and is projected to reach USD 4,106.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Vaccines Market Scope
DNA Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global dna vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna vaccines market will help companies and investors design strategic landscapes.
Recombinant vaccine was the largest segment with a revenue share of 100% in 2020. Horizon Databook has segmented the Global dna vaccines market based on recombinant vaccine covering the revenue growth of each sub-segment from 2017 to 2028.
- Global DNA Vaccines Technology Outlook (Revenue, USD Million, 2017-2028)
- Recombinant vaccine
- Gene-based vaccine
- Global DNA Vaccines Type Outlook (Revenue, USD Million, 2017-2028)
- Therapeutic vaccine
- Preventive vaccine
- Global DNA Vaccines Application Outlook (Revenue, USD Million, 2017-2028)
- Oncology
- Infectious diseases
- Allergies
- Others
Reasons to subscribe to Global dna vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global dna vaccines market databook
-
Our clientele includes a mix of dna vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global dna vaccines market , including forecasts for subscribers. This global databook contains high-level insights into Global dna vaccines market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Global dna vaccines market size, by region, 2017-2028 (US$M)
Top 10 countries: Dna vaccines market size, 2020 (US$M)
Global dna vaccines market share, by technology, 2020 & 2028 (%, US$M)
Dna vaccines market: Opportunity assessment by country
Global dna vaccines market, by region, 2020 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
